Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
ICH REQUIREMENTS FOR QUALIFICATION OF IMPURITIES IN NEW MOLECULAR ENTITIES SHOULD APPLY TO GENERIC AND OTC DRUGS, FDA AD HOC ADVISORY CMTE. AGREES
Jun 28 1993
•
By
The Pink Sheet
More from Archive
More from Pink Sheet